News Articles and Montana BioScience Alliance Newsletters
Five UM public health master’s students working on projects that tackle some of the largest health issues facing the state and region recently earned the regional Student Leaders in Public Health Award from the Rocky Mountain Public Health Training Center in the Colorado School of Public Health. The award provides $3,500 to each project.
Microbion Corporation today announced that a Phase 2, randomized, controlled study has been initiated to assess the safety and efficacy of topical pravibismane for the treatment of subjects with moderate infections of chronic diabetic foot ulcers (DFU).
Montana State University Billings alumnus Jon Laurent, Ph.D., was recently inducted into the Montana Bioscience Alliance Hall of Fame for his critical role in COVID-19 testing research during the COVID-19 pandemic.
Four public health master’s students at the University of Montana are working on projects that tackle some of the largest health issues facing the state and region. The students recently earned the regional Student Leaders in Public Health Award from the Rocky Mountain Public Health Training Center in the Colorado School of Public Health. The award provides $3,500 to each project.
The new, three-year project aims at improving access throughout Montana to often life-saving treatments available through clinical trials. Funded with nearly $750,000 from biotechnology company Genentech through a grant aimed at advancing equitable access to health care, the project seeks to optimize portions of Billings Clinic’s electronic health record systems for clinical trials and engage underserved communities to let more people in the state receive clinical trial care.
SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]
FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.
Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.
Doctors have told health services to prepare for a new era of cancer screening after a study found a simple blood test could spot multiple cancer types in patients before they develop clear symptoms.
It’s been 60 years since President Kennedy delivered his iconic moonshot speech, marking a goal for America to launch a man into space to step foot on the moon, and bring him back to Earth. On Sept. 12, President Biden gave a speech at the Kennedy Presidential Library in Boston, outlining the progress on his own self-described moonshot: ending cancer.
View the Winter 2022 now!
View the Fall 2022 now!